Page 2
Mawsonia has won a Queen’s Award for Enterprise
Global University Venturing's publisher Mawsonia has been named a 2021 recipient of the Queen's Award for Enterprise: International Trade.
Lifetime Achievement Award: Koenraad Debackere
Koenraad Debackere, managing director, KU Leuven Research and Development, and chairman, Gemma Frisius Fund has received the GUV Lifetime Achievement Award 2019
Personality of the Year: Mark Mann
Put in the driving seat of Oxford University Innovation’s new social enterprise campaign, Mark Mann – this year’s Personality of the Year – surely has one of the most fascinating jobs in academic tech transfer.
Investment Unit of the Year: Cambridge Enterprise Seed Funds
With hundreds of university venture funds, internal commercialisation vehicles and third-party firms the reality in today’s innovation ecosystem, selecting the nominees and the winner for Investment Unit of the Year is increasingly challenging.
Exit of the Year: Ziylo
After a year of countless exits in the ecosystem, many among the most significant yet – so much so that five nominees were not enough to recognise them all – the Award for Exit of the Year was one of the most difficult to determine.
Technology of the Year: Apeel Sciences
With the growing focus on food sustainability, University of California (UC) Santa Barbara-founded food preservative developer Apeel Science is a particularly apt selection for the Technology of the Year award.
CVC Investment in a Spinout of the Year: Ribon Therapeutics
Winner of the CVC Investment in a Spinout of the Year: Ribon Therapeutics - Novartis Venture Fund, Johnson & Johnson Innovation–JJDC, Takeda Ventures, Celgene
Fundraising of the Year: Imec.xpand
One only has to look at the investors in the €117m ($135m) final close for Imec.xpand, the venture fund of nano-electronics research institute Imec, to see why it is worthy of GUV’s Fundraising of the Year award.
Deal of the Year: Galecto Biotech
Of the strong candidates for GUV’s Deal of the Year, Lund and Edinburgh universities-founded drug developer Galecto Biotech sealed the award for a €79m ($90m) series C close that supplemented a promising set of clinical data for its lead candidate.
Tech Transfer Unit of the Year: ETH transfer
ETH transfer won the GUV Award 2019 for Tech Transfer Unit of the Year.